These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32736946)

  • 1. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
    Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
    Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
    Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
    Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
    Li L; Li Q
    Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
    Li Y; Yang X; Lu D
    Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
    Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
    Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
    Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
    Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2T knockdown inhibits gastric cancer progression.
    Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
    Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
    Zhu J; Ao H; Liu M; Cao K; Ma J
    J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.